Metal-Based Anticancer Complexes and p53: How Much Do We Know?

Samah Mutasim Alfadul, Egor M. Matnurov, Alexander E. Varakutin, Maria V. Babak*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

5 Citations (Scopus)
37 Downloads (CityUHK Scholars)

Abstract

P53 plays a key role in protecting the human genome from DNA-related mutations; however, it is one of the most frequently mutated genes in cancer. The P53 family members p63 and p73 were also shown to play important roles in cancer development and progression. Currently, there are various organic molecules from different structural classes of compounds that could reactivate the function of wild-type p53, degrade or inhibit mutant p53, etc. It was shown that: (1) the function of the wild-type p53 protein was dependent on the presence of Zn atoms, and (2) Zn supplementation restored the altered conformation of the mutant p53 protein. This prompted us to question whether the dependence of p53 on Zn and other metals might be used as a cancer vulnerability. This review article focuses on the role of different metals in the structure and function of p53, as well as discusses the effects of metal complexes based on Zn, Cu, Fe, Ru, Au, Ag, Pd, Pt, Ir, V, Mo, Bi and Sn on the p53 protein and p53-associated signaling. © 2023 by the authors. Licensee MDPI, Basel, Switzerland.
Original languageEnglish
Article number2834
JournalCancers
Volume15
Issue number10
Online published19 May 2023
DOIs
Publication statusPublished - May 2023

Research Keywords

  • bioinorganic
  • copper
  • iron
  • metal anticancer complexes
  • p53 family
  • platinum
  • ruthenium
  • zinc

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Metal-Based Anticancer Complexes and p53: How Much Do We Know?'. Together they form a unique fingerprint.

Cite this